Close

Galena Biopharma (GALE) Receives Notice of Allowance for NeuVax Patent

July 1, 2014 7:07 AM EDT Send to a Friend
Galena Biopharma (Nasdaq: GALE) announced the notice of allowance of a U.S. Patent for NeuVax (nelipepimut-S) covering the use of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login